What changed
Cytrellis will place its ellacor system with Micro-Coring Technology into the program's hands-on workshops. The release says nurse practitioners taking the certificate will use the device in a structured classroom setting, not on patients in a clinic.
The support runs per cohort. The program has three cohorts a year, and Cytrellis will provide an ellacor unit, plus tips for using it and supplies, so students can run demonstrations. Cytrellis clinical educators will lead designated workshops, perform live demonstrations and talk through appropriate professional use.
The certificate is a 12-week program for board-certified advanced practice registered nurses. It totals 60 contact hours: 40 hours of on-campus classes and 20 hours of supervised clinical training. Classes meet weekly at the Coral Gables campus.
The release names Daniel L. Campos, DNP, APRN, as the leader of the program and the founder of the Ageless Forever Institute in Coral Gables. He said the ellacor exposure adds "an important dimension" to the hands-on part of the course. Denise Dajles, Cytrellis's CEO, presented the deal as support for "the next generation of aesthetic providers."
What it means for practices
This is a training agreement, not a sales contract. The release does not disclose any money changing hands, and it does not say whether Cytrellis pays AFAAAS or the university. Read it as a device maker getting its hardware in front of a new group of prescribers every few months.
For owners, the useful signal is who the company is courting. Nurse practitioners who finish a university-backed certificate are the people most likely to be hired into or to open their own injectable and device practices in Florida and beyond. A provider who trained on ellacor in school already knows the workflow when your practice asks about it.
The company's own wording is worth reading carefully. Cytrellis calls ellacor the "only FDA-cleared non-surgical treatment that removes excess skin to address moderate and severe wrinkles. It also says the technology removes microscale cores of skin without thermal energy and is aimed at moderate to severe skin laxity in the face and body. Those are two different claims. The release mixes a wrinkle indication with a laxity positioning, and the document does not say which indication the clearance covers or give the clearance number. Check the FDA listing yourself before you repeat either phrase to a patient.
What owners can do
If you employ or supervise nurse practitioners, ask whether any of them are enrolled in or are candidates for this certificate, and whether the 20 supervised clinical hours would count toward your own supervision duties. If you are evaluating ellacor for your practice, ask Cytrellis for the exact FDA clearance wording, the indication it covers, and the training it provides after the classroom session. Ask the same questions of any device vendor that sponsors a course. Training access is a sales tool, and it is fair to treat it as one.
What we don't know yet
The release does not give the number of nurse practitioners per cohort, the tuition, or the enrollment numbers. It does not say whether Cytrellis will sponsor future cohorts beyond the first session, and it does not name a term for the three-cohort commitment. Nothing in the document says whether the University of Miami is a financial party to the deal or only a host for the course. The October 31 session will be the first public look at how the workshops run in practice.
Business information, not medical or legal advice. Verify regulatory status at FDA.gov.
